Aegis Special Situations Fund, LLC - Series Medtech XIII — Form D/A
Aegis Special Situations Fund, LLC - Series Medtech XIII of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-03. The offering totals $11.0M, of which $2.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-11-03
- Form: D/A
- Accession: 0001997594-23-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $11.0M
- Amount sold: $2.0M
- Remaining: $9.0M
- Investors: 44
- Date of first sale: 2023-09-29
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-494793
Issuer
- Name: Aegis Special Situations Fund, LLC - Series Medtech XIII
- CIK: 0001997594
- Entity type: Other
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1345 AVENUE OF THE AMERICAS, NEW YORK, NY, 10105
- Phone: (317) 561-9811
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| - Aegis Capital Holding Corp. | Director | New York, NY |
| - Aegis Special Situations Management LLC | Director | New York, NY |
| Cosme Ordonez | Director | New York, NY |
Other filings by this issuer (1)
More